Press Release: PRAC recommends suspending use of Protelos/Osseor

Author (Corporate)
Series Title
Series Details 10.01.14
Publication Date 10/01/2014
Content Type

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) recommended in January 2014 that Protelos/Osseor should no longer be used to treat osteoporosis.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002005.jsp&mid=WC0b01ac058004d5c1
Related Links
ESO: Background information: Press Release: Recommendation to restrict the use of Protelos/Osseor (strontium ranelate) http://www.europeansources.info/record/press-release-recommendation-to-restrict-the-use-of-protelos-osseor-strontium-ranelate/
Subject Categories
Countries / Regions